BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6176532)

  • 1. Specific unresponsiveness to Corynebacterium parvum as measured by delayed hypersensitivity.
    Bartlett GL; Kreider JW
    Immunol Commun; 1981; 10(8):719-31. PubMed ID: 6176532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
    Gauthier-Rahman S
    Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Corynebacterium parvum on the immune response in guinea pigs. I. Mode of enhancement of the anamnestic response and development of delayted hypersensitivity after treatment with Corynebacterium parvum].
    Halpern B; Gauthier-Rahman S; Besluau D
    C R Seances Soc Biol Fil; 1977; 171(6):1202-8. PubMed ID: 148948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopotentiation of cell-mediated hypersensitivity by Corynebacterium parvum (Propionibacterium acnes).
    Maguire HC; Cipriano D
    Int Arch Allergy Appl Immunol; 1983; 70(1):34-9. PubMed ID: 6848475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW
    Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous unresponsiveness to Mycobacterium bovis BCG in intravenously infected mice.
    Turcotte R; Forget A
    Infect Immun; 1983 Aug; 41(2):453-61. PubMed ID: 6347889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased resistance to Listeria monocytogenes in mice injected with killed corynebacterium parvum: association with suppression of cell-mediated immunity.
    Wing EJ; Kresefsky-Friedman DY
    J Infect Dis; 1980 Feb; 141(2):203-11. PubMed ID: 6767792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of resistance to Listeria monocytogenes enhanced by Corynebacterium parvum in mice.
    Miyata H; Nomoto K; Takeya K
    Immunology; 1980 May; 40(1):33-9. PubMed ID: 6968291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Corynebacterium parvum on the immune response in guinea pigs. II. Passive transfer of enhanced anamnestic response and delayed hypersensitivity observed after treatment with Corynebacterium parvum].
    Halpern B; Gauthier-Rahman S; Besluau D
    C R Seances Soc Biol Fil; 1977; 171(6):1209-16. PubMed ID: 148949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between phagocytic activity of macrophages and delayed footpad reaction against syngeneic testicular cells.
    Nomoto K; Yoshikai Y; Yoshida S; Miake S
    J Clin Lab Immunol; 1982 Feb; 7(2):141-6. PubMed ID: 7069784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
    Scott MT; Warner SL
    Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C. parvum skin testing antigen: study on guinea pig model.
    Roumiantzeff M; Colombet G
    Dev Biol Stand; 1977 Apr 13-15; 38():65-72. PubMed ID: 608551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J; Mara M
    Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
    Fisher B; Wolmark N; Rubin H
    J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-GuĂ©rin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effects of Corynebacterium parvum on primary and secondary antibody responses in mice.
    Ansell JD; Trail KN; McDougall CM; Inchley CJ
    J Reticuloendothel Soc; 1983 Oct; 34(4):311-21. PubMed ID: 6620257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on delayed hypersensitivity to protein antigen. Induction of delayed hypersensitivity by chemically modified antigen.
    Nakashima S; Sakai Y; Take N; Umeda Y
    Microbiol Immunol; 1978; 22(4):215-26. PubMed ID: 99645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
    Scott MT
    J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon inducibility in mice treated with Corynebacterium parvum.
    Storch E; Kirchner H
    Antiviral Res; 1985 Apr; 5(2):117-23. PubMed ID: 2409917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and immunological studies on the cell walls of Propionibacterium acnes strain C7 and Corynebacterium parvum ATCC 11829.
    Azuma I; Sugimura K; Taniyama T; Aladin A; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):265-75. PubMed ID: 811835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.